Cate Lockhart, Pharm.D., Ph.D., spoke at AMCP Nexus about biosimilars, the insulin biosimilar Semglee and the role of PBMs.
Tony Hagen, Senior Editor, The Center for Biosimilars
Advertisement
Articles by Tony Hagen, Senior Editor, The Center for Biosimilars
Jen Norton spoke at AMCP Nexus about biosimilar trends of 2021 and what to expect in the next 12 months
CROs are also adapting to pandemic.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Study finds gaps in recommended cardiac amyloidosis testing
2
From Clinical Trials to Community Practice: Contextualizing Lorlatinib's Durability and Implementing Long-Term Management Strategies
3
Study finds associations between particular speech patterns and particular schizophrenia symptoms
4
ctDNA in the de-escalation of breast cancer therapy. A puzzle not solved.
5